Regeneron Pharmaceuticals, Inc.
Close on Nov 19, 2026Market cap $95.52BP/E 20.4Yield –
Regeneron Pharmaceuticals EYLEA HD & EYLEA Total — U.S. Net Product Sales by Quarter
EYLEA HD & EYLEA Total — U.S. Net Product Sales ($M) ($M)
Regeneron Pharmaceuticals EYLEA HD & EYLEA Total — U.S. Net Product Sales: $1,099M in Q3 2026, down 1.1% from a year earlier.
Where the Q3 2026 figure comes from
Source: Form 10-Q (filed 2026-10-30) ↗
Reported in Form 10-Q / 10-K Note — Net Product Sales (XBRL) & Table 5.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up EYLEA HD & EYLEA Total — U.S. Net Product Sales
Cite this data
StockData. (2026). Regeneron Pharmaceuticals EYLEA HD & EYLEA Total — U.S. Net Product Sales ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/rev-eylea-fran-us
See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.
See a number that looks wrong?